Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY

Alnylam Pharma (ALNY) Stock Forecast & Price Target

898 Followers
See the Price Targets and Ratings of:

ALNY Analyst Ratings

Moderate Buy
15Ratings
10 Buy
5 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Alnylam
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALNY Stock 12 Months Forecast

Average Price Target

$239.00
▲(8.51% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Alnylam Pharma in the last 3 months. The average price target is $239.00 with a high forecast of $415.00 and a low forecast of $145.00. The average price target represents a 8.51% change from the last price of $220.25.
Highest Price Target$415.00Average Price Target$239.00Lowest Price Target$145.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
RBC Capital
$250.00
Buy
13.51%
Upside
Reiterated
Analysts Are Bullish on These Healthcare Stocks: Align Tech (ALGN), Alnylam Pharma (ALNY)
J.P. Morgan
$200.00
Hold
-9.19%
Downside
Reiterated
JP Morgan Maintains Neutral on Alnylam Pharmaceuticals, Lowers Price Target to $200
Jefferies
$232.00
Buy
5.33%
Upside
Reiterated
Alnylam price target raised to $232 from $218 at JefferiesAlnylam price target raised to $232 from $218 at Jefferies
Oppenheimer
$256.00
Buy
16.23%
Upside
Reiterated
Oppenheimer reiterates Alnylam Pharmaceuticals (ALNY) at Outperform on Latest ALN-HSD DataOppenheimer analyst Leland Gershell reiterated an Outperform rating and $256.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY), following report of preliminary Phase 1 data for ALN-HSD.
William Blair
Buy
Reiterated
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ALNY Financial Forecast

ALNY Earnings Forecast
Next quarter’s earnings estimate for ALNY is -$1.83 with a range of -$2.73 to $1.71. The previous quarter’s EPS was -$3.32. ALNY beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.38% of the time in the same period. In the last calendar year ALNY has Underperformed its overall industry.
Next quarter’s earnings estimate for ALNY is -$1.83 with a range of -$2.73 to $1.71. The previous quarter’s EPS was -$3.32. ALNY beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.38% of the time in the same period. In the last calendar year ALNY has Underperformed its overall industry.
ALNY Sales Forecast
Next quarter’s sales forecast for ALNY is $313.09M with a range of $284.00M to $367.90M. The previous quarter’s sales results were $264.31M. ALNY beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.94% of the time in the same period. In the last calendar year ALNY has Underperformed its overall industry.
Next quarter’s sales forecast for ALNY is $313.09M with a range of $284.00M to $367.90M. The previous quarter’s sales results were $264.31M. ALNY beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.94% of the time in the same period. In the last calendar year ALNY has Underperformed its overall industry.
ALNY Analyst Recommendation Trends
In the current month, ALNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALNY average analyst price target in the past 3 months is $239.00
In the current month, ALNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALNY average analyst price target in the past 3 months is $239.00

ALNY Stock Forecast FAQ

What is ALNY’s average 12-month price target, according to analysts?
Based on analyst ratings, Alnylam Pharma’s 12-month average price target is $239.00.
    What is ALNY’s upside potential, based on the analysts’ average price target?
    Alnylam Pharma has 8.51% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALNY a Buy, Sell or Hold?
          Alnylam Pharma has a conensus rating of Moderate Buy which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Alnylam Pharma’s price target?
            The average price target for Alnylam Pharma is $239.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $415.00 ,the lowest forecast is $145.00. The average price target represents 8.51% Increase from the current price of $220.25.
              What do analysts say about Alnylam Pharma?
              Alnylam Pharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis